You are required to be logged in to access the full website
Click here if you have forgotten your username or password
7 August 2026 - Renal-focused biopharmaceutical company Alebund Pharmaceuticals (Jiangsu) Limited (HKEX:09637) announced on Friday that China's National Medical Products Administration (NMPA) has accepted for review its New Drug Application (NDA...
7 August 2026 - Swedish biotech company BioInvent International AB (STO:BINV) announced on Friday that the US Food and Drug Administration (FDA) has granted Fast Track designation to its first-in-class anti-TNFR2 antibody BI-1808, in combination with...
7 August 2026 - NeuroSense Therapeutics Ltd (NASDAQ:NRSN), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, announced on Thursday that it is targeting December 2026 for the...
7 August 2026 - Northwest Biotherapeutics (NWBio) (OTCQB:NWBO), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Thursday that it has entered into a non-binding Memorandum of Understanding ...
7 August 2026 - Medical device manufacturer Amsino International Inc announced on Thursday that it has been awarded a contract by healthcare company Vizient for enteral syringes, effective 1 August 2026.Amsino manufactures enteral syringes in both No...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe